News by subject: TRI

...

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders and...

Chronic gastrointestinal (GI) disorders are becoming increasingly common throughout the world, but many of them still lack effective treatment. Researchers have now turned to natural compounds, such as those present in traditional medicines, to...

Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present an extensive array of hematology/oncology data from their clinical research program at the 65th American Society of Hematology (ASH) Annual Meeting...

Independent study concluded:- IceCure system offers significant advantage in ability to re-treat tumors that are initially resistant, achieving a subsequent local control rate of 100%- 92.4% of patients (N= 24) were discharged the day after...

A multi-institution research team that included Pittsburgh-based Allegheny General Hospital (AGH), the academic flagship of Allegheny Health Network (AHN), has published a groundbreaking clinical study demonstrating that avoidance of aspirin in...

HelixVMtm, a virtual healthcare marketplace, showcases its ability to significantly increase physician capacity, revolutionizing the way healthcare is delivered. The pioneering marketplace platform demonstrated the capability to streamline...

AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its AmacaGel delivery platform, announced the closing of a CAD$4.0 million financing round, with a new lead investor, supported by existing investors; BDC...

Carisma Therapeutics Inc. ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the clearance of its Investigational New Drug application (IND) by...

All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the Investment Canada Act has been achieved and therefore the mutual closing condition with...

Clario, a healthcare...

Julius Clinical Research ("Julius Clinical" or the "Company"), a leading academic clinical Contract Research Organization ("CRO") providing clinical trial services and real-world evidence studies to biopharma sponsors, proudly announces a majority...

RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, today announced its two Phase II, open-label, multicenter, single-arm studies for Disitamab Vedotin (RC48-C005 and RC48-C009) have...

We are thrilled to announce the launch of groundbreaking new features in our software, designed to revolutionize your experience with CT imaging. These latest enhancements, developed with your needs in mind, ensure that your practice remains at the...

New clinical data from Octapharma's haematology portfolio will be presented during the scientific program at the 65th American Society of Hematology (ASH) Meeting and Exposition, which is being held on December 9?12, 2023, in San Diego, California....

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company")  a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, announced today that the FDA  provides clearance on the Company's...

Akeso (9926. HK) has announced that the AK104-303 Phase III trial, which investigated cadonilimab (Akeso's PD-1/CTLA-4 bispecific antibody) combined with platinum-based chemotherapy +/- bevacizumab, has met one of its primary endpoints of...

Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by chronic inflammation and neurodegeneration, today announced that it will be presenting at the upcoming 65th...

Seelos Therapeutics, Inc. ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that SLS-002 (intranasal racemic ketamine) has been...

New clinical data from Octapharma's haematology portfolio will be presented during the scientific program at the 65th American Society of Hematology (ASH) Meeting and Exposition, which is being held on December 9?12, 2023, in San Diego, California....

An exclusive initiative by the Israeli biotechnology company Amorphical brings a breakthrough approach to treating a variety of chronic inflammatory and oncological diseases....

In a study recently published in the journal Scientific Reports, researchers from Shizuoka University, Noster Inc, and other groups in Japan identify gut-bacteria derived metabolites that can mitigate fatty liver disease. Nonalcoholic fatty liver...

Medivir AB , a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that it has finalized the development of an updated formulation of fostrox, suitable for commercial...

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China has...

Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announces today that the US Food and Drug Administration (FDA) has granted...

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody...

PlasCred Circular Innovations Inc. (the "Company" or "PlasCred") , a transformative leader in the plastic waste upcycling sector, proudly announces the initial catalytic test results from its cutting-edge, patent-pending Primus pilot plant in...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced that in a study recently published in European Radiology, Lunit's AI-powered mammography analysis solution, Lunit INSIGHT MMG,...

AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, announced today that two abstracts relating to...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major...

TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, today announced groundbreaking findings from its recent research, heralding a new chapter in company's pursuit of making Boron Neutron Capture...

Legacy Healthcare, a clinical-stage biopharmaceutical company developing transformative medicines for the treatment of autoimmune and inflammatory diseases, continues to be featured in news outlets highlighting the company's lead drug candidate,...

Zymo Research Corporation proudly announced its sponsorship of the upcoming "Microbes in Wastewater: Molecular Approaches in Pathogen and AMR Surveillance" symposium, scheduled for January 18th -19th, 2024, in Laguna Beach, California. Hosted by the...

Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that data from the pivotal trial of revumenib, the Company's highly selective, oral menin inhibitor, will be...

DarioHealth Corp. ("Dario" or the "Company"), a leader in the global digital health market, announced today two new analyses recently presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic in Dario users....

In this free webinar, learn about the FDA Oncology Center of Excellence's special projects and programs. The featured speakers will discuss the focus on new dose optimization requirements through Project Optimus from a medical, scientific and...

Kazia Therapeutics Limited , an oncology-focused drug development company, is pleased to provide key highlights of the clinical and preclinical paxalisib related presentations given by key thought leaders at the Society of Neuro-Oncology 2023 Annual...

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that U.S. Food and Drug Administration has approved its Phase II IND...

As we approach the holiday season, which can be a stressful time of year, Canada's leading clinical arthritis research organization, Arthritis Research Canada, is sharing research findings about the role of self-care in managing arthritis in a free...

The St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, is thrilled to announce $1.1 million in new grants to bolster pediatric cancer clinical trial enrollment. Clinical trials play a crucial role in the fight...

- Data spans eleven presentations across both solid tumors and hematologic malignancies, providing added understanding of the potential benefit these therapies bring to patients - ORSERDU data reinforce its key role in the treatment of ER+, HER2-...

HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market. The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome,...

Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced today a delay of at least 6 months in the initiation of its Primary Sclerosing Cholangitis...

Nicklaus Children's Hospital is to become only the third site in North America involved in a Phase I clinical trial studying the role of a new technology called low-frequency focused ultrasound (LoFU) in the care of children with a lethal type of...

Voltron Therapeutics, Inc., a Lucius Partners portfolio company, today announced that it has finalized the protocol for a Dose-Ranging Efficacy Study of VTX-0P4, a protein-based cancer vaccine targeting Prostate Stem Cell Antigen (PSCA). PSCA is a...

The global clinical trials market size reached USD 48.68 billion in 2022 and is projected to surpass around USD 83.55 billion by 2032, expanding at a CAGR of 5.6% during the forecast period, according to the Precedence Research. The global clinical...

Olympus announced today study results showing the sustained clinical benefits of the Spirationtm Valve System (SVS) in treating patients suffering from the symptoms of severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Patients...

Chengdu Origen Biotechnology Co., Ltd. ("Chengdu Origen") and Vanotech Ltd. ("Vanotech") announced today the first patient dosed in the VAN-2201 multi-center Phase 1 clinical trial evaluating treatment with KH631 for patients with wet Age-related...